HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 28 April 2016

Cochrane Collaboration Issue 4, 2016…

….is almost complete.  It includes dozens of new or updated reviews, including:
  • Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
  • Electrical stimulation with non-implanted electrodes for overactive bladder in adults
  • Laparoscopic versus open distal pancreatectomy for pancreatic cancer
  • Dornase alfa for cystic fibrosis
  • Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
  • High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome
  • Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates